Skip to main content
A therapeutic target to prevent or treat castration-resistant prostate cancer

A therapeutic target to prevent or treat castration-resistant prostate cancer

Unmet Need Prostate cancer is the second leading cause of cancer death in American men. Androgen deprivation therapy has been the standard of care for initial management of advanced prostate cancer, but resistance to therapy…

Read More

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Diagnostic and treatment for chronic and acute phase myeloid leukemia

Value Proposition While cancer therapies have increased survival for many tumor types, the reality is that 50-60% of cancer patients will die from the disease. This highlights a need for the continued search for targeted…

Read More

SUMO as a marker of cancer development and target for cancer therapy

SUMO as a marker of cancer development and target for cancer therapy

Value Proposition Cancer therapy remains challenging, and the production of new inhibitor therapies is stinted by the need for clear successful targets that will block tumor cell proliferation. Small ubiquitin-like modifier (SUMO) proteins and the…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us